We live in a world full of foreign chemicals—whether it’s pesticides on our produce, ingredients in over-the-counter medications, or pollutants in the air. These substances, called xenobiotics, are foreign to the body and need to be broken down and eliminated to protect our health (Kalimuthu, 2024; Patterson et al., 2010). Thankfully, our body has a natural defense mechanism called biotransformation, which takes these potentially harmful compounds and converts them into less toxic, more water-soluble forms so they can be safely excreted (Phang-Lyn & Llerena, 2023).

This blog breaks down how this process works, in simple terms, focusing on hydrolysis, reduction, oxidation, and conjugation—the core phases of biotransformation. I’ll also explain how specific coenzymes from our diet help move these processes along more efficiently.

Fig. 1. Exposure to various toxic chemicals triggers the progression of OS. (b) The rate of oxidative stress in the human body accompanies a wide variety of diseases and pathological disorders that damage the heart, lungs, intestines, joints, muscles, skin, liver, brain, kidneys, eyes, and immune system (Goshtasbi et al., 2025).

Fig. 2. Schematic Metabolism of Xenobiotics. Following uptake, the drug is metabolized in the first phase of biotransformation via oxidation, reduction, or hydroxylation, leading to insertion or uncovering of a reactive hydrophilic moiety, which in the second phase is conjugated with endogenous compounds such as glutathione or saccharides. The resulting conjugate is subsequently excreted by export (efflux) transporters (Matoušková et al., 2016).

🧪 Phase I: Making Xenobiotics More Reactive (Hydrolysis, Reduction, and Oxidation)

The first phase of detoxification involves chemically modifying xenobiotics to either neutralize them or prepare them for further processing in Phase II (Matoušková et al., 2016; Zhang et al., 2009). The goal here is to make the molecule more polar (water-loving) and more chemically reactive.

1. Hydrolysis

Hydrolysis is like adding water to “crack open” a molecule. Enzymes such as esterases and amidases use water to split large, fat-soluble xenobiotics into smaller, more manageable pieces. This process is beneficial for breaking down certain pesticides, drugs, and food additives (Mahanayak, 2024). While hydrolysis makes the compound more reactive, it doesn’t necessarily make it less toxic—so the work isn’t done yet.

2. Reduction

In reduction reactions, oxygen is removed, or hydrogen is added to the molecule. This usually happens in environments where there’s less oxygen, like the intestines or parts of the liver. Reductive enzymes work to break down compounds like nitro groups, carbonyls, or halogens—common in food preservatives and industrial pollutants (Bhandari et al., 2021). The result is a reactive intermediate that’s ready for the next step.

3. Oxidation

Oxidation is the most well-known step in Phase I and is carried out by the cytochrome P450 family of enzymes. These enzymes add oxygen atoms to the xenobiotic, making it more soluble and reactive. But there’s a catch: oxidation can also produce free radicals or unstable intermediates, which can harm cells if not quickly processed (Chaudhary et al., 2023; Tumilaar et al., 2024). This is why Phase II is so important.

🔁 Phase II: Conjugation – The Final Clean-Up

Once Phase I turns a xenobiotic into a reactive intermediate, Phase II steps in to neutralize it and make it easy to eliminate through urine or bile (Zhang et al., 2009; Phang-Lyn & Llerena, 2023). This is done through a process called conjugation, which is basically the act of “tagging” a molecule with another compound that helps it dissolve in water (Panda et al., 2023).

Here are the main types of conjugation:

• Glutathione conjugation – Uses the antioxidant glutathione to neutralize toxins, especially heavy metals and solvents (Cassier-Chauvat et al., 2023).
• Methylation – Adds a methyl group to deactivate certain chemicals and hormones (De Clercq, 2023; Menezo et al., 2020).
• Sulfation – Adds a sulfate group to make the substance more water-soluble (Li et al., 2021).
• Glucuronidation – Uses glucuronic acid to help detoxify drugs, hormones, and pollutants (Takahashi, 2024).

These reactions all require specific nutrients or coenzymes to function properly.

🥬 Nutrients & Coenzymes That Support Detoxification

Here’s where diet and lifestyle come in. The body can’t run these detox pathways without the proper cofactors—many of which come from the foods we eat.

Some of the most essential coenzymes and nutrients include:

• Glutathione – Found in cruciferous vegetables (like broccoli and Brussels sprouts), this powerful antioxidant fuels Phase II detox and protects the liver from oxidative damage (Nho & Jeffery, 2001; Yan & Yan, Y, 2023).
• B Vitamins (especially B2, B6, B12, and folate) – These help with methylation and enzyme function. You can get them from leafy greens, legumes, and whole grains (Savic et al., 2025).
• Magnesium – Supports hundreds of enzyme reactions, including detoxification. Found in pumpkin seeds, spinach, and avocados.
• Selenium and Zinc – Trace minerals that support glutathione function and antioxidant defense.
• Vitamin C and E – Help reduce oxidative stress and regenerate other antioxidants.

Including these nutrients in your diet—either through food or supplementation—helps your liver keep up with daily detox demands.

Conclusion

Detoxification is more than a buzzword. It’s a real, ongoing process that your liver performs every second of the day. The biotransformation of xenobiotics is a sophisticated and complex system that uses hydrolysis, reduction, and oxidation to transform dangerous compounds into manageable ones. Then, through conjugation, your body can safely remove them through our waste.

But this system isn’t automatic—it depends on what nutrients and minerals we feed our bodies. By eating a nutrient-rich diet and minimizing exposure to harmful chemicals, we can support our liver’s ability to filter out the bad and keep us feeling our best.

References

Armani, S., Geier, A., Forst, T., Merle, U., Alpers, D. H., & Lunnon, M. W. (2024). Effect of changes in metabolic enzymes and transporters on drug metabolism in the context of liver disease: Impact on pharmacokinetics and drug–drug interactions. British Journal of Clinical Pharmacology, 90(4), 942-958. https://doi.org/10.1111/bcp.15990

Bhandari, S., Poudel, D. K., Marahatha, R., Dawadi, S., Khadayat, K., Phuyal, S., ... & Parajuli, N. (2021). Microbial enzymes used in bioremediation. Journal of Chemistry, 2021(1), 8849512. https://doi.org/10.1155/2021/8849512

Cassier-Chauvat, C., Marceau, F., Farci, S., Ouchane, S., & Chauvat, F. (2023). The glutathione system: a journey from cyanobacteria to higher eukaryotes. Antioxidants, 12(6), 1199. https://doi.org/10.3390/antiox12061199

Chaudhary, P., Janmeda, P., Docea, A. O., Yeskaliyeva, B., Abdull Razis, A. F., Modu, B., Calina, D., & Sharifi-Rad, J. (2023). Oxidative stress, free radicals and antioxidants: potential crosstalk in the pathophysiology of human diseases. Frontiers in Chemistry, 11, 1158198. https://doi.org/10.3389/fchem.2023.1158198 

De Clercq, E. (2023). The magic of a methyl group: Biochemistry at the service of medicine. Biochemical Pharmacology, 216, 115786. https://doi.org/10.1016/j.bcp.2023.115786

Goshtasbi, H., Hashemzadeh, N., Fathi, M., Movafeghi, A., Barar, J., & Omidi, Y. (2025). Mitigating oxidative stress toxicities of environmental pollutants by antioxidant nanoformulations. Nano TransMed, 100087. https://doi.org/10.1016/j.ntm.2025.100087

Li, J., Chiew, A. L., Isbister, G. K., & Duffull, S. B. (2021). Sulfate conjugation may be the key to hepatotoxicity in paracetamol overdose. British Journal of Clinical Pharmacology, 87(5), 2392-2396. https://doi.org/10.1111/bcp.14642 

Kalimuthu, V. P. (2024). Xenoviotics: A Hidden Danger to Human Health. In Life Sciences Trends and Technology, vol 3. Scieng Publication

Mahanayak, B. (2024). Biotransformation reactions of xenobiotics: mechanisms and implications for environmental and human health. World Journal of Biology Pharmacy and Health Sciences, 19(1), 158-164. https://doi.org/10.30574/wjbphs.2024.19.1.0406 

Menezo, Y., Clement, P., Clement, A., & Elder, K. (2020). Methylation: An Ineluctable Biochemical and Physiological Process Essential to the Transmission of Life. International Journal of Molecular Sciences, 21(23), 9311. https://doi.org/10.3390/ijms21239311 

Nho, C. W., & Jeffery, E. (2001). The synergistic upregulation of phase II detoxification enzymes by glucosinolate breakdown products in cruciferous vegetables. Toxicology and Applied Pharmacology, 174(2), 146–152. https://doi.org/10.1006/taap.2001.9207 

Panda, C., Komarnytsky, S., Fleming, M. N., Marsh, C., Barron, K., Le Brun-Blashka, S., & Metzger, B. (2023). Guided metabolic detoxification program supports phase II detoxification enzymes and antioxidant balance in healthy participants. Nutrients, 15(9), 2209. https://doi.org/10.3390/nu15092209

Patterson, A. D., Gonzalez, F. J., & Idle, J. R. (2010). Xenobiotic metabolism: a view through the metabolometer. Chemical Research in Toxicology, 23(5), 851–860. https://doi.org/10.1021/tx100020p 

Phang-Lyn, S. & Llerena, V. A. (2023, Aug. 14) Biochemistry, Biotransformation. StatPearls [Internet]. https://www.ncbi.nlm.nih.gov/books/NBK544353/

Savic, B., Savic, B., & Stanojlovic, S. (2025). Epigenetic DNA Methylation Under the Influence of Low-Dose Ionizing Radiation, and Supplementation with Vitamin B12 and Folic Acid: Harmful or Beneficial for Professionals?. Epigenomes, 9(2), 17. https://doi.org/10.3390/epigenomes9020017

Takahashi, K. (2024). Role of Glucuronidation in Drug Detoxification and Elimination. International Journal of Pharmaceutical, Chemical & Biological Sciences, 14(3). https://www.ijpcbs.com/articles/role-of-glucuronidation-in-drug-detoxification-and-elimination.pdf 

Tumilaar, S. G., Hardianto, A., Dohi, H., & Kurnia, D. (2024). A Comprehensive Review of Free Radicals, oxidative stress, and antioxidants: Overview, clinical applications, global perspectives, future directions, and mechanisms of antioxidant activity of flavonoid compounds. Journal of Chemistry, 2024(1), 5594386. https://doi.org/10.1155/2024/5594386

Yan, L., & Yan, Y. (2023). Therapeutic potential of sulforaphane in liver diseases: a review. Frontiers in Pharmacology, 14, 1256029. https://doi.org/10.3389/fphar.2023.1256029 

Zhang, Q., Pi, J., Woods, C. G., & Andersen, M. E. (2009). Phase I to II cross-induction of xenobiotic metabolizing enzymes: a feedforward control mechanism for potential hormetic responses. Toxicology and Applied Pharmacology, 237(3), 345–356. https://doi.org/10.1016/j.taap.2009.04.005